Theravance Biopharma Inc (NASDAQ:TBPH)

14.38
Delayed Data
As of May 22
 -0.11 / -0.76%
Today’s Change
13.11
Today|||52-Week Range
35.67
-3.62%
Year-to-Date

Today’s Trading

Previous close14.49
Today’s open14.41
Day’s range14.18 - 14.67
Volume128,753
Average volume (3 months)159,708
Market cap$486.1M
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-52.24%
Earnings growth (this year)+30.23%
Earnings growth (next 5 years)+9.62%
Revenue growth (last year)+5,071.68%
P/E ratioNM
Price/Sales40.54
Price/Book1.60

Competitors

 Today’s
change
Today’s
% change
LBIOLion Biotechnologies...+0.10+0.94%
SRNESorrento Therapeutic...-0.27-2.04%
SCLNSciClone Pharmaceuti...+0.14+1.51%
PETXAratana Therapeutics...-0.10-0.74%
Data as of 4:14pm ET, 05/22/2015

Financials

Next reporting dateAugust 12, 2015
EPS forecast (this quarter)-$0.90
Annual revenue (last year)$11.7M
Annual profit (last year)-$237.0M
Net profit margin-2,028.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Rick E. Winningham
Senior Vice President-
Operations
Frank C. Pasqualone
Corporate headquarters
George Town, George Town

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers